Pneumothorax Treatment Devices Market Analysis Highlights Growth To $6.43 Billion By 2030 At 10% CAGR

The pneumothorax treatment devices market is on track for significant expansion in the coming years, driven by technological progress and increasing demand in emergency care. This sector is witnessing rapid innovation to meet healthcare needs, particularly in critical and emergency settings.

Forecasted Market Size for Pneumothorax Treatment Devices by 2030
The value of the pneumothorax treatment devices market is projected to reach $6.43 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.0%. This upward trajectory is fueled by the rise in portable emergency medical devices, ongoing improvements in thoracic vent systems, increased ICU admissions, and a growing need for quicker lung re-expansion therapies. Additionally, the expansion of emergency medical services is contributing significantly to market growth. Key trends shaping this market include rapid lung decompression techniques, the development of portable pneumothorax management tools, minimally invasive chest drainage systems, enhanced air leak control technologies, and streamlined bedside treatment kits.

Download a free sample of the Pneumothorax Treatment Devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20929&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Steering the Pneumothorax Treatment Devices Market
The market is dominated by several prominent players, including Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton dic*kinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., and Selio Medical Inc.

A notable development in this space occurred in June 2023, when Merit Medical Systems, Inc., a US-based medical technology company specializing in interventional, diagnostic, and critical care products, acquired AngioDynamics, Inc. for $100 million in cash. This acquisition aims to broaden Merit Medical's portfolio, particularly in interventional oncology and lung biopsy complication management, through the integration of the BioSentry system-a device designed to significantly reduce biopsy-related pneumothorax cases. AngioDynamics, Inc. is well-known as a US-based medical device manufacturer focusing on minimally invasive vascular, oncology, and biopsy-related products, making this a strategic move to strengthen Merit Medical's standing in the global pneumothorax treatment devices market while also enhancing its offerings in vascular access and dialysis care.

View the full Pneumothorax Treatment Devices market report:
https://www.thebusinessresearchcompany.com/report/pneumothorax-treatment-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Shaping the Future of Pneumothorax Treatment Devices
Industry leaders in the pneumothorax treatment device market are increasingly channeling efforts into developing advanced technologies like chest X-ray imaging solutions to maintain a competitive edge. Chest X-ray solutions encompass a range of imaging systems and equipment designed to capture detailed radiographs of the chest area, including lungs, heart, ribs, and nearby structures.

For example, in September 2023, Qure.ai, a US-based health technology company, obtained 510(k) FDA clearance for its cutting-edge chest X-ray product called qXR-PTX-PE. This AI-powered software is engineered to aid in the swift detection of pneumothorax (PTX) and pleural effusion (PE), substantially improving patient care in intensive care units (ICUs) and emergency rooms (ERs). By providing real-time alerts to healthcare providers, the solution enhances triage efficiency where rapid identification of such critical conditions is essential to patient outcomes.

Largest Market Segments within Pneumothorax Treatment Devices
The pneumothorax treatment devices market is segmented by type, application, and end-user categories for a comprehensive understanding.

By type, the market includes ventilator devices, thoracic vent devices, and other types of devices. Ventilator devices are further classified into portable ventilators, non-invasive ventilators, and invasive ventilators. Thoracic vent devices consist of chest drainage systems, Heimlich valves, and one-way chest valve systems. Other device types include needle aspiration devices, pleural catheters, and oxygen therapy devices.

Application-wise, the market segments cover traumatic pneumothorax, spontaneous pneumothorax, and other applications. Regarding end-users, hospitals, ambulatory surgical centers, and other healthcare facilities form the key customer base.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.